A

ABPro Bio Co Ltd
KOSDAQ:195990

Watchlist Manager
ABPro Bio Co Ltd
KOSDAQ:195990
Watchlist
Price: 1 859 KRW 30%
Market Cap: ₩52.9B

Balance Sheet

Balance Sheet Decomposition
ABPro Bio Co Ltd

Balance Sheet
ABPro Bio Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
16 936
29 264
27 540
4 720
21 062
4 245
7 030
14 957
26 840
53 961
16 951
18 856
15 495
Cash
0
4
18
18
9
8
52
13
1
7
14
8
7
Cash Equivalents
16 936
29 260
27 522
4 702
21 053
4 237
6 978
14 944
26 839
53 954
16 938
18 848
15 488
Short-Term Investments
401
0
3 000
55 371
31 642
3 308
0
10
4 045
0
4 087
72
5 743
Total Receivables
6 203
4 983
25 492
15 109
20 571
21 650
19 875
10 765
5 013
4 331
4 554
6 113
12 389
Accounts Receivables
6 203
4 291
25 339
15 069
15 387
17 236
11 970
4 208
4 126
2 781
3 237
4 035
10 005
Other Receivables
0
692
153
40
5 184
4 414
7 905
6 557
887
1 550
1 316
2 079
2 384
Inventory
9 105
14 338
18 646
24 452
26 730
27 058
25 187
16 886
12 664
15 189
18 610
16 432
13 534
Other Current Assets
436
909
11 313
1 876
3 604
14 410
7 533
38 806
9 246
8 422
1 591
3 330
1 820
Total Current Assets
33 081
49 494
85 991
101 527
103 609
70 671
59 625
81 426
57 808
81 903
45 793
44 804
48 981
PP&E Net
14 531
14 218
30 632
31 390
30 913
59 136
53 259
49 738
39 552
24 170
23 099
22 579
21 574
PP&E Gross
0
14 218
30 632
31 390
30 913
59 136
53 259
49 738
39 552
24 170
23 099
22 579
21 574
Accumulated Depreciation
0
4 264
2 926
4 321
5 889
9 407
12 906
11 931
17 886
13 368
14 210
15 056
8 297
Intangible Assets
185
247
170
470
629
436
7 460
5 242
500
3 621
2 388
3 482
3 338
Goodwill
0
0
0
0
0
8 594
14 602
6 873
0
0
0
8 004
13 496
Note Receivable
0
315
212
174
254
295
1 203
385
256
33
4 841
3 952
7 873
Long-Term Investments
474
580
1 069
2 164
28 582
27 986
34 285
52 667
61 656
57 305
79 769
56 410
43 492
Other Long-Term Assets
851
828
1 332
1 301
2 434
4 811
6 037
6 540
6 256
852
756
2 879
2 510
Other Assets
0
0
0
0
0
8 594
14 602
6 873
0
0
0
8 004
13 496
Total Assets
49 122
N/A
65 682
+34%
119 407
+82%
137 027
+15%
166 421
+21%
171 929
+3%
176 471
+3%
202 871
+15%
166 028
-18%
167 884
+1%
156 646
-7%
142 110
-9%
141 263
-1%
Liabilities
Accounts Payable
7 373
10 301
15 982
2 204
8 182
6 138
2 457
1 346
2 227
2 911
1 559
2 127
6 855
Accrued Liabilities
0
917
930
814
779
983
2 125
2 067
2 258
479
860
1 024
772
Short-Term Debt
0
0
5 658
2 708
6 064
10 797
5 745
2 601
2 495
0
0
1 975
3 040
Current Portion of Long-Term Debt
3 549
11 536
0
0
26 065
36 677
38 922
24 459
196
21 228
10 499
7 975
7 050
Other Current Liabilities
3 018
786
6 442
2 804
4 876
7 536
3 575
33 793
7 656
5 143
3 091
4 824
3 298
Total Current Liabilities
13 940
23 540
29 013
8 530
45 967
62 131
52 824
64 265
14 831
29 760
16 009
17 925
21 015
Long-Term Debt
275
0
22 429
22 429
5 720
6 449
4 191
14 387
8 705
583
441
1 844
11 963
Deferred Income Tax
1 339
1 461
1 174
2 225
89
607
2 000
1 071
0
0
0
0
213
Minority Interest
0
0
0
0
4 572
4 433
10 221
1 743
902
0
0
0
0
Other Liabilities
0
0
0
0
418
675
357
3 960
4 294
0
0
0
60
Total Liabilities
15 553
N/A
25 001
+61%
52 616
+110%
33 184
-37%
56 765
+71%
74 294
+31%
69 593
-6%
85 426
+23%
26 928
-68%
30 343
+13%
16 450
-46%
19 769
+20%
33 251
+68%
Equity
Common Stock
3 930
3 930
4 914
11 549
36 747
36 894
49 231
88 382
125 735
130 102
136 845
142 345
142 345
Retained Earnings
32 612
36 446
48 485
60 065
56 849
45 251
33 941
9 920
68 918
79 070
87 193
112 935
128 564
Additional Paid In Capital
0
3 221
13 541
31 933
15 949
16 522
25 628
39 398
84 005
85 635
87 288
89 116
89 786
Unrealized Security Profit/Loss
0
11
20
31
310
0
736
47
287
1 292
0
0
0
Treasury Stock
0
0
0
0
0
3
3
3
3
3
3
3
3
Other Equity
2 974
2 927
168
265
199
1 029
1 183
365
2 006
2 169
3 259
3 817
4 448
Total Equity
33 569
N/A
40 681
+21%
66 791
+64%
103 843
+55%
109 656
+6%
97 635
-11%
106 878
+9%
117 445
+10%
139 100
+18%
137 541
-1%
140 196
+2%
122 340
-13%
108 012
-12%
Total Liabilities & Equity
49 122
N/A
65 682
+34%
119 407
+82%
137 027
+15%
166 421
+21%
171 929
+3%
176 471
+3%
202 871
+15%
166 028
-18%
167 884
+1%
156 646
-7%
142 110
-9%
141 263
-1%
Shares Outstanding
Common Shares Outstanding
47
47
52
69
73
74
98
177
251
260
274
285
285
Preferred Shares Outstanding
0
0
1
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett